Clinical Trial Update: Exogenous Melatonin in Postmenopausal Women with Insomnia [NA]

View source ↗

Summary

The clinical trial evaluating exogenous melatonin for insomnia in postmenopausal women has been terminated. No results are reported in the update.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insomnia

Drugs mentioned

• Melatonin (melatonin)

Snippet

Sponsor: Douglas Mental Health University Institute | Conditions: Insomnia | NA | Status: TERMINATED